Sectra begins implementation of its first digital pathology project in Japan, aiming to improve cancer diagnostics and decrease time to treatment

LINKÖPING, Sweden, Jan. 7, 2026 /PRNewswire/ -- International medical technology and cybersecurity company Sectra (STO: SECT B), in collaboration with distribution partner Matsunami Glass has commenced the implementation phase of its first digital pathology project in Japan. This milestone marks Sectra's entry into the Japanese digital pathology market and highlights the potential of its technology to advance diagnostic capabilities and support the country's evolving healthcare needs.